Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Central administration of donepezil improves long-term heart failure prognosis in vivo

Sep. 5, 2016

Apixaban equivalent to warfarin in AF patients with cancer

Sep. 5, 2016

Omecamtiv mecarbil enters phase III clinical development

Sep. 2, 2016

Intramyocardial AdVEGF-DdNdC gene therapy shows potential in patients with refractory angina

Sep. 1, 2016

Aptahem reports on anticoagulant effect of APTA-1 in animal studies

Sep. 1, 2016

Scientists identify novel disease-causing mutations in DSP gene

Sep. 1, 2016

Good Doctor Pharmaceutical Group reports new PDE inhibitors

Sep. 1, 2016

Novel desmin mutation causes left-dominant arrhythmogenic cardiomyopathy

Aug. 31, 2016

Selenoprotein T gene therapy ameliorates experimental heart failure

Aug. 30, 2016

Novel WNK inhibitor demonstrates promise as antihypertensive agent in vivo

Aug. 30, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...